COLON CANCER NEWS TIPS & FEATURES


OMNI Health Media is a leading online provider of Daily Health News. OMNI’s Colon Cancer News provides summaries of developments in the prevention, screening, and management of Gastrointestinal Health Conditions as they are discovered and reported by physicians and scientists around the world. Our mission is to provide this news, including results of recent clinical trials evaluating new therapies and supportive care strategies in order to better educate patients and their caregivers, ensuring timely access to the best care available.
Many Early Onset Colon Cancers are Caused by Genetic Mutations Passed Through Families

April 25, 2018

Many Early Onset Colon Cancers are Caused by Genetic Mutations Passed Through Families

By Anonymous User anonymous_user_10987

CancerConnect News: One in every six colorectal cancer patients (16 percent) diagnosed under age 50 has at least one inherited genetic mutation that increases his or her cancer risk and many of these mutations could go undetected with the current screening approach, according to initial data from a statewide colorectal cancer screening study conducted at […]

View full entry

Tags: Colon Cancer, hereditary, lynch syndrome, News Tips and Features, News Tips and Features Other, ohio state-james cancer institute


Managing Side Effects From EGFR Inhibitors

April 10, 2018

Managing Side Effects From EGFR Inhibitors

By Anonymous User anonymous_user_10987

CancerConnect News: Epidermal Growth Factor Receptor (EGFR) inhibitor drugs are a type of precision cancer medicine commonly used to treat lung, colon, head and neck and other cancers that over express the EGFR.  There are several EGFR inhibitor drugs and these cause similar side effects. The EGFR pathway is a normal biologic pathway found in […]

View full entry

Tags: cetuximab, Colon Cancer, diarrhea, EGFR inhibitors, erbitux, Erlotinib, Gefitinib, Head and Neck Cancer, iressa, Lung Cancer, News Tips and Features, News Tips and Features Other


Larotrectinib Demonstrates 76 Percent Response Rate in TRK Fusion Cancers Including Colo-rectal Cancer

March 29, 2018

Larotrectinib Demonstrates 76 Percent Response Rate in TRK Fusion Cancers Including Colo-rectal Cancer

By cancerconnect cancerconnect

CancerConnect News: Clinical data from three ongoing larotrectinib (LOXO-101) clinical trials in patients whose tumors harbor tropomyosin receptor kinase (TRK) fusions demonstrating a 76 percent confirmed objective response rate (ORR) across tumor types, were published today in the New England Journal of Medicine after an initial summary presentation at the American Society of Clinical Oncology […]

View full entry

Tags: Colon Cancer, colorectal cancer, News Tips and Features, News Tips and Features Other, Rectal Cancer


Opdivo Combined with Yervoy Appears Promising for Patients with dMMR or MSI-H Advanced Colorectal Cancer

March 27, 2018

Opdivo Combined with Yervoy Appears Promising for Patients with dMMR or MSI-H Advanced Colorectal Cancer

By cancerconnect cancerconnect

CancerConnect News: New data from the phase 2 CheckMate -142 trial evaluating Opdivo (nivolumab) and Yervoy (ipilimumab) for the treatment of patients with DNA mismatch repair deficient (dMMR) or microsatellite instability-high (MSI-H) metastatic colorectal cancer presentated at the 2018 Gastrointestinal Cancers Symposium in San Francisco, Calif., and simultaneously published in the Journal of Clinical Oncology […]

View full entry

Tags: Colon Cancer, colorectal cancer, News Tips and Features, News Tips and Features Other


Diagnosed with Colon Cancer: 10 Tips on How to Get The Most From Your Doctor

February 21, 2018

Diagnosed with Colon Cancer: 10 Tips on How to Get The Most From Your Doctor

By Anonymous User anonymous_user_10987

1) Choose Your Doctor Carefully Medical oncologists are the primary doctors involved with colon cancer and work in collaboration with surgeons and gastroenterologists. Pick a medical oncologist carefully, rely on people you trust including nurses and other health care professionals who make help with recommendations.  Make sure your doctor is someone you feel comfortable interacting […]

View full entry

Tags: Colon Cancer, News Tips and Features, News Tips and Features Other


Start 2018 Right: Plan for Cancer Screening and Save Lives!

January 5, 2018

Start 2018 Right: Plan for Cancer Screening and Save Lives!

By Anonymous User anonymous_user_10987

Screening guidelines should initiate conversations with your healthcare team.  Charles H Weaver MD, Editor CancerConnect CancerConnect News: The goal of cancer screening is to find disease at early stages in people who are otherwise asymptomatic—before it causes symptoms and when it may be more easily treatable.  Screening tests are not available for every type of […]

View full entry

Tags: breast, Breast Cancer, cancer screening, Colon, Colon Cancer, lung, Lung Cancer, News Tips and Features, News Tips and Features Other, Skin Cancer


Living with a Colostomy

November 3, 2017

Living with a Colostomy

By cancerconnect cancerconnect

Approximately 10-15% of patients with colorectal cancer require a colostomy. Colostomy refers to a surgical procedure where a portion of the large intestine is brought through the abdominal wall to carry stool out of the body. During a colostomy, a surgeon will create an opening between the intestine and the abdominal wall. This opening is […]

View full entry

Tags: Colon Cancer, News Tips and Features, Rectal Cancer


Targeting both BRAF and EGFR doubles progression-free survival in metastatic colorectal cancer

October 16, 2017

Targeting both BRAF and EGFR doubles progression-free survival in metastatic colorectal cancer

By Anonymous User anonymous_user_10987

Recent successes in genetically targeted precision cancer medicines are improving outcomes in a number of cancers.  Ensuring patients undergo genomic sequencing to determine if they have treatable targets is increasingly important to ensure patients receive the most appropriate personalized care. Precision cancer medicine utilizes molecular diagnostic testing, including DNA sequencing, to identify cancer-driving abnormalities in […]

View full entry

Tags: BRAF, Colon Cancer, erbitux, News Tips and Features, News Tips and Features Other, Precision Cancer Medicine, Rectal Cancer, V600E, vemurafenib, Zelboraf


View more articles like this
More news and in-depth Colon Cancer information

CONDITIONS OF THE GI TRACT